OTUD6B and cancer: The role of OTUD6B-AS1 in different cancers varies: for example, over-expression of OTUD6B-AS1 in kidney cancer acts on the wnt/β-catenin pathway to inhibit cancer development and metastasis 14; OTUD6B-AS1 is a biomarker of ovarian cancer occurrence and prognosis 16, and high expression of OTUD6B‐AS1 is closely associated with poor prognosis of ovarian cancer 17.